key: cord-0323161-9mp3wrn3
authors: D'Onofrio, V.; Heylen, D.; Pusparum, M.; Grondman, I.; Vanwalleghem, J.; Meersman, A.; Cartuyvels, R.; Messiaen, P.; Joosten, L. A. B.; Netea, M. G.; Valkenborg, D.; Ertaylan, G.; Gyssens, I. C.
title: A prospective observational cohort study to identify inflammatory biomarkers for the diagnosis and prognosis of patients with sepsis
date: 2021-06-21
journal: nan
DOI: 10.1101/2021.06.16.21259042
sha: 38d853610edc554e4e459c9a6770b10b86399947
doc_id: 323161
cord_uid: 9mp3wrn3

Background: Sepsis is a life-threatening organ dysfunction. A fast diagnosis is crucial for patient management. Proteins that are synthesized during the inflammatory response can be used as biomarkers, helping in a rapid clinical assessment or an early diagnosis of infection. The aim of this study was to identify biomarkers of inflammation for the diagnosis and prognosis of infection in patients with suspected sepsis. Methods: In total 406 episodes were included in a prospective cohort study. Plasma was collected from all patients on the first day of a new episode. Samples were analysed using a 92-plex proteomic panel based on a proximity extension assay with oligonucleotide-labelled antibody probe pairs (OLink, Uppsala, Sweden). Supervised and unsupervised differential expression analyses and pathway enrichment analyses were performed. Results: Supervised differential expression analysis revealed 21 proteins that were significantly lower in circulation of patients with viral infections compared to patients with bacterial infections. More strongly, higher expression levels were observed for 38 proteins in patients with high SOFA scores (>4), and for 21 proteins in patients with worse outcome. These proteins are mostly involved in pathways known to be activated early in the inflammatory response. Unsupervised, hierarchical clustering confirmed that inflammatory response was more strongly related to disease severity than to aetiology. Conclusion: Several differentially expressed inflammatory proteins were identified that could be used as biomarkers for sepsis. These proteins are mostly related to disease severity. Within the setting of an emergency department, they could be used for outcome prediction, patient monitoring, and directing diagnostics.

Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection 55 [1, 2] . Septic shock is a subset of sepsis in which profound circulatory, cellular, and metabolic 56 abnormalities are associated with a greater risk of mortality than with sepsis alone [1] . In patients 57 with sepsis, the fast initiation of antibiotic therapy is crucial and each hour delay results in increased 58 risk of mortality [3] . The causative event is an invading pathogen, most frequently Escherichia coli, 59 Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella species, but also influenza virus. 

Leukocytosis is associated with bacterial infection, and highly increased CRP levels correlate with a 77 positive sensitivity for bacterial infection [6] [7] [8] [9] . Additionally, procalcitonin (PCT), a pro-inflammatory 78 biomarker released by monocytes and macrophages, correlates with inflammation intensity and 79 highly increased concentrations are seen in bacterial infections [7] [8] [9] . Although PCT is able to 80 discriminate between bacterial and viral community-acquired pneumonia, a multi-marker approach 81 seems more reliable [6, 8] . Biomarkers can help in providing a rapid clinical assessment of patients 82 and predict disease severity. Therefore, they could improve outcomes by rapidly guiding triage and 83 the start of adequate treatment [9, 10] . A faster diagnosis of the infection and the likely causative 84 pathogen, will lead to a faster start of targeted antimicrobial therapy, thereby reducing selective 85 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 

This is a sub-study in which patients with primary BSI, pneumonia, influenza, urosepsis, or other 

Blood cultures, EDTA samples for complete blood count (CDC) and serum and heparin plasma 108 samples for basic laboratory parameters assessing organ function were obtained for each patient at 109 the start of each new episode. Two 9 mL EDTA blood samples were drawn from the same 110 venepuncture. EDTA samples were stored at 4°C until written informed consent was obtained for a 111 maximum of three days. Samples were transferred to the University Biobank Limburg (UBiLim) and 112 centrifuged at 400g for 10 minutes. Plasma was separated and centrifuged at 1500g for 10 minutes.

Four aliquots of 500µL plasma were stored at UBiLim [12] for each patient at -80°C until further 114 analysis.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 21, 2021. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 21, 2021. 

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 21, 2021. Table 1 ). Therefore, the following analyses were performed based on plotting these four 206 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. clustering could confirm supervised differential expression i.e., that some differences between viral 236 (influenza) and bacterial infections were found, but that inflammatory proteins more strongly 237 indicated disease severity.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

Indeed, the observation that inflammatory protein expression profile is related to sepsis severity, 300 has recently been described in patients with COVID-19, using the same targeted proteomic approach 301 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 21, 2021. ; https://doi.org/10.1101/2021.06.16.21259042 doi: medRxiv preprint

[31]. Differentially expressed proteins in COVID-19 patients were involved in the same pathways 302 found in the present study [24, 27, 31] . This strengthens our finding that these proteins could be 303 more useful for the prognosis of patients with severe infections, rather than for the aetiologic 304 diagnosis.

One major strength of this study is the use of a large cohort of patients who were prospectively 306 included and uniformly defined. The results of this study show the importance of the host response 307 in predicting patient outcome. The unicentric nature of this study is a limitation resulting in a difficult 308 extrapolation to other centres. Furthermore, we did not compare our findings with a non-sepsis 309 control population, and therefore lack information on basic expression levels. Last, there were no 310 follow-up plasma samples during patients' hospitalization, and we were not able to assess the impact 311 of later events on patient outcome.

In conclusion, the inflammatory response of patients with viral infection differed from the response is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 21, 2021. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 21, 2021. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 21, 2021. ; https://doi.org/10.1101/2021.06.16.21259042 doi: medRxiv preprint Worse outcome # 96 23.6) * Disease severity based on SOFA score at the start of a new episode. # Patients who were admitted to the ICU or who died during hospitalization were classified in the worse outcome group. All variables are presented as number (%) unless otherwise specified.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 21, 2021. ; https://doi.org/10.1101/2021.06.16.21259042 doi: medRxiv preprint 

The Third 369 International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

Sepsis and septic shock: New 372 definitions, new diagnostic and therapeutic approaches

Duration of hypotension 374 before initiation of effective antimicrobial therapy is the critical determinant of survival in human 375 septic shock

The immunopathology of sepsis 379 and potential therapeutic targets

Biomarkers of sepsis

Importance of Markers of Sepsis in Surgical 382 Patients

Diagnosing sepsis -The role of laboratory medicine

Expert Rev Anti Infect al. Macrophage activation-like syndrome: an immunological entity associated with rapid progression 396 to death in sepsis

Management 400 of community-acquired pneumonia in adults: 2016 guideline update from the Dutch Working Party 401 on Antibiotic Policy (SWAB) and Dutch Association of Chest Physicians (NVALT)

United States. Department of Health and Human Services, United States. Food and Drug 404

Complicated urinary tract infections 405 : developing drugs for treatment

Communicable Diseases in Europe

Homogenous 412 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability

Sepsis biomarkers: a review

Biomarkers in Sepsis: A Systematic Review

Serum procalcitonin and C-reactive 422 protein levels as markers of bacterial infection: a systematic review and meta-analysis

Plasma Proteomics Identify Biomarkers and 425 Pathogenesis of COVID-19

Derivation, Validation, 427 the author/funder, who has granted medRxiv a license to display the preprint in perpetuity

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 21, 2021. ; https://doi.org/10.1101/2021.06.16.21259042 doi: medRxiv preprint 21 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)The copyright holder for this preprint this version posted June 21, 2021. ; https://doi.org/10.1101/2021.06.16.21259042 doi: medRxiv preprint